公司資料
Carisma Therapeutics, Inc. 股價、新聞與催化劑
- 股票代碼:
- CARM
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
0.00 USD (-47.83%)
收盤價
最後更新: 2026年8月21日
—
市值
股價為何變動
As of Aug 21, 2026, CARM closed down 47.8% at $0.0012. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Carisma Therapeutics is a cell-therapy company focused on engineered macrophages and cancer immunotherapy. Its story centers on using a novel immune-cell approach to attack tumors.
所在地與產業分類
Carisma is headquartered in the United States and listed on NASDAQ. It sits in cell therapy and oncology biotechnology.
商業模式特徵
The company depends on clinical validation, manufacturing feasibility, and capital support while it advances a narrow pipeline. Investors watch early data and platform differentiation.
生技產業定位
Carisma occupies a specialized macrophage-cell-therapy niche within biotech. It is catalyst-sensitive because the platform still needs to prove itself clinically.
未來催化劑
- Carisma’s catalysts are macrophage-engineering programs and any strategic or clinical update that clarifies the company’s next path. The company still needs stronger human proof.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。